Pulse 探索 nav.journalClub 辩论趋势研究者期刊

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

首页探索 nav.journalClub 趋势

⌘+K

The economic burden of moderate-to-severe rheumatoid arthritis in Spain: the CIARA study | Synapse

April 3, 2026Journal of Medical Economics0 citationsOpen Access

View Full Paper

The economic burden of moderate-to-severe rheumatoid arthritis in Spain: the CIARA study

LSLucía Silva-FernándezComplexo Hospitalario Universitario A Coruña ACAlejandro Balsa CriadoHospital Universitario La Paz RSRaimon SanmartíHospital Clínic de Barcelona

Key Points

This research aims to evaluate the economic impact of moderate-to-severe rheumatoid arthritis in Spain.
Utilized data from the CIARA study.
Analyzed costs related to out-of-pocket expenses and productivity.
Examined the impact of switching to advanced therapies.
Advanced therapies reduced out-of-pocket expenses.
Observed decreased productivity losses.
Higher pharmaceutical costs were not fully offset by these savings.

Abstract

Switching to advanced therapies reduced out-of-pocket expenses and productivity losses. Although this reduction did not offset higher pharmaceutical spending, it may reflect clinical improvements.

问 AI

Like

Bookmark

Share

View Full Paper

问 AI

Like

Bookmark

Share

View Full Paper

Cite This Study

Silva-Fernández et al. (Tue,) studied this question.

synapsesocial.com/papers/69cf5f645a333a821460e95d https://doi.org/https://doi.org/10.1080/13696998.2026.2644119